Directory

>

Rebecca Bagley

avatar

Rebecca Bagley

Executive Director, Clinical Sciences, Revumenib Lead | Syndax Pharmaceuticals

Boston, Massachusetts, United States

View contact details (it's free)

Rebecca Bagley

Summary

Rebecca Bagley is a highly experienced clinical scientist specializing in oncology, with a robust career spanning over a decade in the pharmaceutical industry. Currently serving as the Executive Director at Syndax Pharmaceuticals, she leads clinical sciences and is the Revumenib Lead. Her expertise encompasses a wide array of areas including assay development, clinical trials, and regulatory affairs, showcasing her comprehensive understanding of drug development processes. Rebecca has a strong academic background with a Bachelor's and Master's degree in Biology from Wellesley College and Harvard University, respectively. Known for her organizational skills and critical data analysis, she has contributed significantly to IND submissions and clinical protocols. Her prior roles at leading companies like Radius Health and Sanofi have further solidified her reputation as a thought leader in clinical research. With a passion for advancing oncology therapeutics, Rebecca is committed to improving patient outcomes through innovative clinical strategies.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Rebecca Bagley

Work Experience

company logo

Executive Director, Clinical Sciences, Revumenib Lead at

Syndax Pharmaceuticals

July 2023 - Present

company logo

Senior Director at

Syndax Pharmaceuticals

October 2020 - July 2023

company logo

Director, Clinical Development at

Radius Health, Inc.

December 2018 - October 2020

company logo

Associate Director, Clinical Science at

Celldex Therapeutics

July 2016 - December 2018

company logo

Senior Clinical Scientist at

Celldex Therapeutics

February 2015 - July 2016

company logo

Clinical Scientist at

Sanofi

November 2011 - January 2015

company logo

Senior Scientist at

SANOFI-AVENTIS AUSTRALIA PTY LTD

September 2007 - November 2011

Logos provided by Logo.dev

Rebecca Bagley

Education

Wellesley College, Bachelor’s Degree

Harvard University, Master’s Degree

Frequently Asked Questions about Rebecca Bagley

What is Rebecca Bagley email address?

Rebecca Bagley's primary email address is *******@syndax.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Rebecca Bagley work for?

Rebecca Bagley is a Executive Director, Clinical Sciences, Revumenib Lead at Syndax Pharmaceuticals, a company specializing in Commercial physical research.

Where Rebecca Bagley graduated from?

Rebecca Bagley holds a degree in Biology from Wellesley College.

How can I directly contact Rebecca Bagley?

To contact Rebecca Bagley directly, you can use the email address *******@syndax.com. Complete contact information is available upon registration with Muraena.

Who is Rebecca Bagley?

Rebecca Bagley is a highly experienced clinical scientist specializing in oncology, with a robust career spanning over a decade in the pharmaceutical industry. Currently serving as the Executive Director at Syndax Pharmaceuticals, she leads clinical sciences and is the Revumenib Lead. Her expertise encompasses a wide array of areas including assay development, clinical trials, and regulatory affairs, showcasing her comprehensive understanding of drug development processes. Rebecca has a strong academic background with a Bachelor's and Master's degree in Biology from Wellesley College and Harvard University, respectively. Known for her organizational skills and critical data analysis, she has contributed significantly to IND submissions and clinical protocols. Her prior roles at leading companies like Radius Health and Sanofi have further solidified her reputation as a thought leader in clinical research. With a passion for advancing oncology therapeutics, Rebecca is committed to improving patient outcomes through innovative clinical strategies.

Rebecca`s contact details

mail

*******@syndax.com

Colleagues

avatar
Peter Ordentlich

Chief Scientific Officer

Gloria Lee

VP, clinical development

avatar
Michelle Busa

Executive Director, Clinical Data Management

avatar
Soujanya Sunkaraneni

Executive Director, Head of DMPK & Clinical pharmacology

avatar
Shaliny Kushwaha

Vice President Regulatory Affairs and QA

avatar
Sharon Klahre

Vice President, Investor Relations and Corporate Communications

Tyson Kamikawa

Vice President Information Technology

avatar
Deirdre Vitale

Vice President, Talent and Experience

View Contact details (it's free)
Request Profile Removal